These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 3000175

  • 1. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
    Greene DA, Lattimer SA.
    Am J Med; 1985 Nov 15; 79(5A):13-7. PubMed ID: 3000175
    [Abstract] [Full Text] [Related]

  • 2. A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing.
    Greene DA.
    Metabolism; 1986 Apr 15; 35(4 Suppl 1):60-5. PubMed ID: 2421135
    [Abstract] [Full Text] [Related]

  • 3. Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve.
    Greene DA.
    Drugs; 1986 Apr 15; 32 Suppl 2():6-14. PubMed ID: 3024950
    [Abstract] [Full Text] [Related]

  • 4. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR, Hawthorne JN, Tomlinson DR.
    Diabetologia; 1983 Oct 15; 25(4):365-71. PubMed ID: 6416913
    [Abstract] [Full Text] [Related]

  • 5. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K, Kato N, Matsubara A, Nakano K, Kurono M.
    Metabolism; 1992 Oct 15; 41(10):1081-6. PubMed ID: 1328819
    [Abstract] [Full Text] [Related]

  • 6. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
    Greene DA, Mackway AM.
    Diabetes; 1986 Oct 15; 35(10):1106-8. PubMed ID: 3019804
    [Abstract] [Full Text] [Related]

  • 7. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity.
    Greene DA, Lattimer SA.
    Diabetes; 1984 Aug 15; 33(8):712-6. PubMed ID: 6086432
    [Abstract] [Full Text] [Related]

  • 8. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH, Tomlinson DR.
    Diabetologia; 1983 Nov 15; 25(5):433-8. PubMed ID: 6197336
    [Abstract] [Full Text] [Related]

  • 9. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE, Plurad SB, Sherman WR, Williamson JR, Tilton RG.
    Diabetes; 1989 May 15; 38(5):569-79. PubMed ID: 2497038
    [Abstract] [Full Text] [Related]

  • 10. Aldose reductase inhibitors and late complications of diabetes.
    Benfield P.
    Drugs; 1986 May 15; 32 Suppl 2():43-55. PubMed ID: 3098544
    [Abstract] [Full Text] [Related]

  • 11. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR, Moriarty RJ, Mayer JH.
    Diabetes; 1984 May 15; 33(5):470-6. PubMed ID: 6202576
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA.
    Int J Exp Diabetes Res; 2002 May 15; 3(1):21-36. PubMed ID: 11900277
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy.
    Jaspan JB, Herold K, Bartkus C.
    Am J Med; 1985 Nov 15; 79(5A):24-37. PubMed ID: 3000176
    [Abstract] [Full Text] [Related]

  • 16. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
    Sima AA, Bril V, Nathaniel V, McEwen TA, Brown MB, Lattimer SA, Greene DA.
    N Engl J Med; 1988 Sep 01; 319(9):548-55. PubMed ID: 3136331
    [Abstract] [Full Text] [Related]

  • 17. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats.
    Hirata Y, Fujimori S, Okada K.
    Metabolism; 1988 Feb 01; 37(2):159-63. PubMed ID: 2828821
    [Abstract] [Full Text] [Related]

  • 18. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats.
    Yeh LA, Rafford CE, Goddu KJ, Ashton MA, Beyer TA, Hutson NJ.
    Diabetes; 1987 Dec 01; 36(12):1414-9. PubMed ID: 2824260
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.